The Difference in Potential Harms between Whole Blood and Component Blood Transfusion in major Bleeding: A Rapid Systematic Review and Meta-Analysis of RCTs.


Journal

Transfusion medicine reviews
ISSN: 1532-9496
Titre abrégé: Transfus Med Rev
Pays: United States
ID NLM: 8709027

Informations de publication

Date de publication:
01 2022
Historique:
received: 30 07 2021
revised: 20 10 2021
accepted: 21 10 2021
pubmed: 1 12 2021
medline: 6 5 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

Our aim was to assess whether there is a difference in outcomes of potential "all-cause" harm in the transfusion of whole blood (WB) compared to blood components (BC) for any bleeding patient regardless of age or clinical condition. We searched multiple electronic databases using a pre-defined search strategy from inception to 2

Identifiants

pubmed: 34844826
pii: S0887-7963(21)00059-6
doi: 10.1016/j.tmrv.2021.10.003
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-15

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Louise J Geneen (LJ)

Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, UK. Electronic address: louise.geneen@nhsbt.nhs.uk.

Susan J Brunskill (SJ)

Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, UK.

Carolyn Doree (C)

Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, UK.

Lise J Estcourt (LJ)

Systematic Review Initiative, NHS Blood and Transplant, John Radcliffe Hospital, Oxford, UK; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, UK; Haematology/Transfusion Medicine, NHS Blood and Transplant, UK.

Laura Green (L)

Haematology/Transfusion Medicine, NHS Blood and Transplant, UK; Barts Health NHS Trust, London, UK; Blizard Institute, Queen Mary, University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH